Algae Dynamics Corp. (ADYNF) Takes the Safe Road in Cannabis Delivery
- Focused on developing remedies from cannabis oil
- Research programs in conjunction with Universities of Waterloo & Western Ontario
- Strategy to capture market share of non-smoke MMJ nutraceuticals
To acquire the benefits of cannabis, there are many pathways, with some being distinctly safer than others. There are tinctures and topicals; there is dabbing; and there is vaping. There are drinks and digestibles and, of course, there is smoking. Over the last few decades, what some wits refer to as ‘puffing the magic dragon’ has emerged as the top delivery method for users of cannabis, but smoking harms nearly every organ of the body and causes many diseases, according to the Centers for Disease Control (CDC) (http://nnw.fm/CA7Pe). Given such adverse aftereffects, interest in safer delivery options, like those made possible by technology from Algae Dynamics Corp. (OTC: ADYNF), has grown. Algae Dynamics is an innovative biotech currently engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company plans to be a global leader in the formulation and development of health products from cannabis derivatives, algae oils and other botanical oils.
The days when inhaling and exhaling tobacco fumes was regarded as chic or sophisticated are long gone. Now that the danger from cigarettes has been laid bare, the glamour long associated with them has evaporated much as their smoke does. Smoking is responsible for about 480,000 deaths each year in the United States; that is nearly one in five deaths, a figure that exceeds the combined fatalities due to HIV, illegal drug use, alcohol, motor vehicle accidents and gun-related incidents. Notably, ‘more than 10 times as many U.S. citizens have died prematurely from cigarette smoking than have died in all the wars fought by the United States’, according to the U.S. Surgeon General (http://nnw.fm/4DSlH). These compelling statistics, together with government and private initiatives, have raised awareness of the threats posed by smoking, which extend not only to the use of tobacco but also to the newly emerging therapeutic treatments based on cannabis.
In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat some mental health issues and various forms of cancer. The program at the University of Western Ontario is studying the effects of cannabis oil on depression, post-traumatic stress disorder (PTSD), anxiety and schizophrenia, while research at the University of Waterloo is examining ways of treating colorectal, pancreas, breast and prostate cancers.
To support these research efforts, Algae Dynamics announced in August 2017 that it would be collaborating with Bonify, a Licensed Producer (LP), under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, to engage in the extraction of cannabis oil, according to MarketWatch (http://nnw.fm/Cb1wu). The joint initiative entails the purchase and installation of cannabis oil extraction equipment by ADYNF at Bonify’s facility in Winnipeg, Canada. This deal will secure cannabis material for extraction and will generate revenue. As well, the cannabis oil thus produced will be supplied to the University of Waterloo and University of Western Ontario to support the Sponsored Research Agreements that ADYNF has in place with the two universities.
The market for cannabis oil is still in its embryonic stage, but it is likely to grow quickly, spurred by recent trends. A 2016 Mackie Research Capital report, extrapolating data from Colorado, one of the first U.S. states to legalize marijuana, estimates that 45 percent of dried marijuana users would eventually convert to marijuana extracts and/or oils. New Cannabis Ventures even billed cannabis extracts as ‘The Next Canadian Oil Boom’ (http://nnw.fm/a4dOI) after a court ruling allowing LPs to produce cannabis extracts. The Canadian cannabis oil extraction market is projected to grow to C$1.7 billion by 2020. With legalization for recreational use set for July 2018, safer delivery routes for cannabis therapeutics like those engineered by Algae Dynamics are sorely needed to help customers and patients avoid the hazards of smoking.
For more information, visit the company’s website at www.AlgaeDynamics.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Focused on developing remedies from cannabis oil
- Research programs in conjunction with Universities of Waterloo & Western Ontario
- Strategy to capture market share of non-smoke MMJ nutraceuticals
To acquire the benefits of cannabis, there are many pathways, with some being distinctly safer than others. There are tinctures and topicals; there is dabbing; and there is vaping. There are drinks and digestibles and, of course, there is smoking. Over the last few decades, what some wits refer to as ‘puffing the magic dragon’ has emerged as the top delivery method for users of cannabis, but smoking harms nearly every organ of the body and causes many diseases, according to the Centers for Disease Control (CDC) (http://nnw.fm/CA7Pe). Given such adverse aftereffects, interest in safer delivery options, like those made possible by technology from Algae Dynamics Corp. (OTC: ADYNF), has grown. Algae Dynamics is an innovative biotech currently engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company plans to be a global leader in the formulation and development of health products from cannabis derivatives, algae oils and other botanical oils.
The days when inhaling and exhaling tobacco fumes was regarded as chic or sophisticated are long gone. Now that the danger from cigarettes has been laid bare, the glamour long associated with them has evaporated much as their smoke does. Smoking is responsible for about 480,000 deaths each year in the United States; that is nearly one in five deaths, a figure that exceeds the combined fatalities due to HIV, illegal drug use, alcohol, motor vehicle accidents and gun-related incidents. Notably, ‘more than 10 times as many U.S. citizens have died prematurely from cigarette smoking than have died in all the wars fought by the United States’, according to the U.S. Surgeon General (http://nnw.fm/4DSlH). These compelling statistics, together with government and private initiatives, have raised awareness of the threats posed by smoking, which extend not only to the use of tobacco but also to the newly emerging therapeutic treatments based on cannabis.
In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat some mental health issues and various forms of cancer. The program at the University of Western Ontario is studying the effects of cannabis oil on depression, post-traumatic stress disorder (PTSD), anxiety and schizophrenia, while research at the University of Waterloo is examining ways of treating colorectal, pancreas, breast and prostate cancers.
To support these research efforts, Algae Dynamics announced in August 2017 that it would be collaborating with Bonify, a Licensed Producer (LP), under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, to engage in the extraction of cannabis oil, according to MarketWatch (http://nnw.fm/Cb1wu). The joint initiative entails the purchase and installation of cannabis oil extraction equipment by ADYNF at Bonify’s facility in Winnipeg, Canada. This deal will secure cannabis material for extraction and will generate revenue. As well, the cannabis oil thus produced will be supplied to the University of Waterloo and University of Western Ontario to support the Sponsored Research Agreements that ADYNF has in place with the two universities.
The market for cannabis oil is still in its embryonic stage, but it is likely to grow quickly, spurred by recent trends. A 2016 Mackie Research Capital report, extrapolating data from Colorado, one of the first U.S. states to legalize marijuana, estimates that 45 percent of dried marijuana users would eventually convert to marijuana extracts and/or oils. New Cannabis Ventures even billed cannabis extracts as ‘The Next Canadian Oil Boom’ (http://nnw.fm/a4dOI) after a court ruling allowing LPs to produce cannabis extracts. The Canadian cannabis oil extraction market is projected to grow to C$1.7 billion by 2020. With legalization for recreational use set for July 2018, safer delivery routes for cannabis therapeutics like those engineered by Algae Dynamics are sorely needed to help customers and patients avoid the hazards of smoking.
For more information, visit the company’s website at www.AlgaeDynamics.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
